NCTD Prevents Renal Interstitial Fibrosis via Targeting Sp1/lncRNA Gm26669 Axis

In our previous study, we demonstrated that norcantharidin (NCTD) is a potential therapeutic agent for renal interstitial fibrosis (RIF). Recently, we found that lncRNA Gm26669 (Gm26669) contributed to the development of RIF and could be regulated by NCTD. However, the upstream mechanisms of Gm26669...

Descripción completa

Detalles Bibliográficos
Autores principales: Tian, Jiao, Xiao, Zheng, Wei, Ju, Shan, Yi, Zeng, Dong, Tao, Yilin, Fang, Xi, Tang, Chengyuan, Chen, Xiaojun, Li, Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2021
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8375230/
https://www.ncbi.nlm.nih.gov/pubmed/34421354
http://dx.doi.org/10.7150/ijbs.59195

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8375230/
https://www.ncbi.nlm.nih.gov/pubmed/34421354
http://dx.doi.org/10.7150/ijbs.59195

Ejemplares similares